Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents

Cholestatic liver disease is a disease that causes liver damage and fibrosis owing to bile stasis. It is represented by primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), but the pathophysiological pathways that cause bile stasis in both diseases are different. The pathogene...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Sho, Yoneda, Masato, Kurita, Yusuke, Nogami, Asako, Honda, Yasushi, Hosono, Kunihiro, Nakajima, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282588/
https://www.ncbi.nlm.nih.gov/pubmed/34142342
http://dx.doi.org/10.1007/s40265-021-01545-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282588/
https://www.ncbi.nlm.nih.gov/pubmed/34142342
http://dx.doi.org/10.1007/s40265-021-01545-7

Ejemplares similares